Asthma study in Chinese adults to find better treatment matches
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study looks at how asthma affects people in China and tries to find patterns that might help predict which treatments work best. If you have asthma and are between 18 and 75, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with asthma by a doctor for at least 3 months.
- You are not pregnant and do not have a history of alcohol or drug abuse in the past year.
- You have not had a respiratory infection (like a cold or flu) in the last 2 weeks.
- You have not used certain asthma medications (like montelukast or zileuton) in the last month, and no biologic drugs in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults with asthma in real life to better understand asthma care and outcomes. You may be invited if you already joined another asthma-related or health-related observational study and don’t have certain major lung or health conditions.
This trial looks at people with severe asthma that is hard to control. It aims to find and treat specific health problems that make asthma worse, by doing a detailed check-up and using treatments that are right for you.
This study follows adults with asthma to better understand the disease and help improve care. It checks basic eligibility such as diagnosis, language, and recent health history.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This trial studies new technologies to help doctors diagnose asthma and better understand airway inflammation. It may help you (or healthy volunteers, if eligible) by allowing your breathing tests and inflammation markers to be measured with newer diagnostic tools.
This trial looks at how certain proteins (Transgelin-2, Metallothionein-2, and Ezrin) are associated with asthma. It may help researchers better understand asthma biology and potentially guide future treatments.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.